|
Real-time
OTC Markets
10:54:58 2026-06-03 EDT
|
5-day change | 1st Jan Change | ||
| 0.0770 USD | -.--% |
|
-3.74% | -16.75% |
| 25-08-29 | Altamira Therapeutics Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| 25-08-29 | Altamira Therapeutics Ltd., H1 2025 Earnings Call, Aug 29, 2025 |
Company Valuation: Altamira Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 5.35 | 29.91 | 26.91 | 5.671 | 1.384 | 0.3759 |
| Change | - | 459.11% | -10.02% | -78.93% | -75.59% | -72.84% |
| Enterprise Value (EV) 1 | 3.965 | 19.18 | 26.51 | 11.99 | 0.8662 | -0.2617 |
| Change | - | 383.64% | 38.22% | -54.78% | -92.77% | -130.21% |
| P/E | - | -1.92x | -1.38x | -0.17x | -0.44x | -0.04x |
| PBR | 1.11x | 1.78x | 2.14x | -0.69x | 0.8x | 0.08x |
| PEG | - | - | 0.37x | -0x | 0x | 0x |
| Capitalization / Revenue | - | - | 421,323,659x | 18,554,722x | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -0.55x | -3.64x | -1.71x | -0.88x | - | - |
| EV / EBIT | -0.55x | -3.63x | -1.7x | -0.87x | -0.15x | 0.04x |
| EV / FCF | -0.47x | -4.31x | -2.2x | -1.63x | -0.09x | 0.08x |
| FCF Yield | -214% | -23.2% | -45.5% | -61.2% | -1,060% | 1,321% |
| Dividend per Share 3 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 3 | - | -545.4 | -525.1 | -582.6 | -7.876 | -2.986 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | 0.0639 | 0.3056 | - | - |
| EBITDA 1 | -7.228 | -5.263 | -15.52 | -13.69 | - | - |
| EBIT 1 | -7.259 | -5.283 | -15.57 | -13.74 | -5.916 | -6.851 |
| Net income 1 | -6.632 | -8.2 | -17.39 | -26.53 | -3.869 | -8.458 |
| Net Debt 1 | -1.385 | -10.73 | -0.4085 | 6.316 | -0.5178 | -0.6376 |
| Reference price 3 | 648.0000 | 1,048.0000 | 726.0000 | 97.0000 | 3.4800 | 0.1105 |
| Nbr of stocks (in thousands) | 8.26 | 28.5 | 37.1 | 58.5 | 398 | 3,402 |
| Announcement Date | 4/16/20 | 3/31/21 | 4/12/22 | 5/16/23 | 4/10/24 | 4/30/25 |
1USD in Million2CHF in Million3USD
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CYTOF Stock
- Valuation Altamira Therapeutics
Select your edition
All financial news and data tailored to specific country editions
